Zinc in PDB 5f5c: Crystal Structure of Human JMJD2D Complexed with KDOPP7

The structure of Crystal Structure of Human JMJD2D Complexed with KDOPP7, PDB code: 5f5c was solved by T.Krojer, M.Vollmar, L.Crawley, A.R.Bradley, A.Szykowska, G.F.Ruda, H.Yang, N.Burgess-Brown, P.Brennan, C.Bountra, C.H.Arrowsmith, A.Edwards, U.Oppermann, F.Von Delft, Structural Genomics Consortium (Sgc), with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å)	51.92 / 1.88
Space group	P 43 21 2
Cell size a, b, c (Å), α, β, γ (°)	71.594, 71.594, 150.790, 90.00, 90.00, 90.00
R / Rfree (%)	17.2 / 21.1

The structure of Crystal Structure of Human JMJD2D Complexed with KDOPP7 also contains other interesting chemical elements:

Nickel

(Ni)

1 atom

The binding sites of Zinc atom in the Crystal Structure of Human JMJD2D Complexed with KDOPP7 (pdb code 5f5c). This binding sites where shown within 5.0 Angstroms radius around Zinc atom.
In total only one binding site of Zinc was determined in the Crystal Structure of Human JMJD2D Complexed with KDOPP7, PDB code: 5f5c:

Zinc binding site 1 out of 1 in the Crystal Structure of Human JMJD2D Complexed with KDOPP7


Mono view


Stereo pair view

A full contact list of Zinc with other atoms in the Zn binding site number 1 of Crystal Structure of Human JMJD2D Complexed with KDOPP7 within 5.0Å range: probe atom residue distance (Å) B Occ A:Zn401 b:16.6 occ:1.00 SG A:CYS238 2.2 15.8 1.0 NE2 A:HIS244 2.2 15.4 1.0 SG A:CYS310 2.2 17.9 1.0 SG A:CYS312 2.4 21.1 1.0 CB A:CYS238 3.1 17.2 1.0 CE1 A:HIS244 3.2 15.3 1.0 CD2 A:HIS244 3.2 15.0 1.0 CB A:CYS312 3.2 23.4 1.0 CB A:CYS310 3.4 17.2 1.0 N A:CYS312 4.0 24.2 1.0 CA A:CYS310 4.1 17.6 1.0 CA A:CYS312 4.1 25.1 1.0 O A:HOH588 4.2 22.1 1.0 CB A:GLU314 4.3 37.0 1.0 ND1 A:HIS244 4.3 15.0 1.0 CG A:HIS244 4.4 14.6 1.0 CA A:CYS238 4.5 17.9 1.0 N A:GLU314 4.5 35.3 1.0 C A:CYS310 4.5 19.1 1.0 N A:SER311 4.6 20.7 1.0 N A:ALA315 4.7 39.6 1.0 C A:CYS312 4.7 27.5 1.0 O A:ALA240 4.7 14.5 1.0 O A:HOH830 4.7 31.9 1.0 CA A:PHE241 4.8 13.4 1.0 N A:GLY313 4.8 29.3 1.0 CG A:GLU314 4.9 39.3 1.0 CA A:GLU314 4.9 37.1 1.0 O A:HOH607 4.9 35.2 1.0 C A:ALA240 4.9 15.1 1.0

V.Bavetsias, R.M.Lanigan, G.F.Ruda, B.Atrash, M.G.Mclaughlin, A.Tumber, N.Y.Mok, Y.V.Le Bihan, S.Dempster, K.J.Boxall, F.Jeganathan, S.B.Hatch, P.Savitsky, S.Velupillai, T.Krojer, K.S.England, J.Sejberg, C.Thai, A.Donovan, A.Pal, G.Scozzafava, J.M.Bennett, A.Kawamura, C.Johansson, A.Szykowska, C.Gileadi, N.A.Burgess-Brown, F.Von Delft, U.Oppermann, Z.Walters, J.Shipley, F.I.Raynaud, S.M.Westaway, R.K.Prinjha, O.Fedorov, R.Burke, C.J.Schofield, I.M.Westwood, C.Bountra, S.Muller, R.L.Van Montfort, P.E.Brennan, J.Blagg. 8-Substituted Pyrido[3,4-D]Pyrimidin-4(3H)-One Derivatives As Potent, Cell Permeable, KDM4 (JMJD2) and KDM5 (JARID1) Histone Lysine Demethylase Inhibitors. J.Med.Chem. V. 59 1388 2016.
ISSN: ISSN 0022-2623
PubMed: 26741168
DOI: 10.1021/ACS.JMEDCHEM.5B01635